Tiger Brokers

US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

BioNTech SE

96.85
-1.4500-1.48%
Pre-market: 97.650.8000+0.83%08:56 EDT
Volume:820.11K
Turnover:79.91M
Market Cap:24.33B
PE:-12.46
High:99.49
Open:97.59
Low:96.60
Close:98.30
52wk High:124.00
52wk Low:79.52
Shares:251.20M
Float Shares:109.00M
Volume Ratio:1.09
T/O Rate:0.75%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.7726
EPS(LYR):-5.5184
ROE:-9.30%
ROA:-5.41%
PB:1.22
PE(LYR):-17.55

Loading ...

OverviewCompanyNewsFilings

Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Lakefront Biotherapeutics (LKFT) and BioNTech SE (BNTX)

TIPRANKS
·
Aug 31

CanSino Leads HK-Listed Vaccine Makers Lower as BioNTech Halts mRNA Trial

Reuters
·
Aug 31

BioNTech SE Slides as Bold HIV Bet Takes Shape

TIPRANKS
·
Aug 29

BioNTech SE ADR Falls 8.4%, Underperforms Market

Dow Jones
·
Aug 29

Biontech SE Stock (BNTX) Closed Down by 8.37% on Aug 28: What Signal Does It Send?

TradingKey
·
Aug 29

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna's Big Win

Dow Jones
·
Aug 29

BioNTech on Track for Worst Day Since March After Ending Colorectal Cancer Trial

Reuters
·
Aug 29

BioNTech Stock (BNTX) Is Tumbling on Friday – Here’s Why

TIPRANKS
·
Aug 29

Cevumeran trial termination a ‘clear setback’ for BioNTech, says BMO Capital

TIPRANKS
·
Aug 29

U.S. Stocks on the MOVE-Halliburton, BioNTech, Kazia Therapeutics

Reuters
·
Aug 29

Top Midday Stories: Warsh Says Inflation Data 'Concerning'; Advent, Stripe Drop $50 Billion Bid to Buy PayPal

MT Newswires Live
·
Aug 28

European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading

MT Newswires Live
·
Aug 28

mRNA immunotherapy discontinuation a negative for BioNTech, says Morgan Stanley

TIPRANKS
·
Aug 28

Market Movers | GAP Jumps 18%; Affirm Jumps 14%; IREN Stock Drops 7%; Rubrik Falls 6%; BioNTech Falls 9%

Tiger Newspress
·
Aug 28

BioNTech Halts Phase 2 mRNA Monotherapy Trial in Resected Colorectal Cancer After DSMB Review

TIPRANKS
·
Aug 28

Movement Alert｜BioNTech SE Falls 8.22% in Regular Trading, Terminates Phase 2 Cancer Immunotherapy Trial While COVID Vaccine Approval Narrows

Market Focus
·
Aug 28

BioNTech Terminates Phase 2 Trial of Autogene Cevumeran in Colorectal Cancer

MT Newswires Live
·
Aug 28

BioNTech to Terminate Mid-Stage Trial of MRNA Cancer Vaccine

Reuters
·
Aug 28

Movement Alert｜BioNTech SE Falls 11.62% in Pre-Market Trading, COVID-19 Vaccine Approved but Eligible Population Sharply Narrowed

Market Focus
·
Aug 28

FDA Approves Seasonal Covid-19 Vaccines from Moderna, Pfizer, BioNTech

Dow Jones
·
Aug 28
More